# Ezetimibe (Zetia)

Source: https://ourhealthnetwork.com/drugs/ezetimibe
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Ezetimibe?

Ezetimibe (brand name: Zetia) is a HMG-CoA reductase inhibitor. It is prescribed to treat hyperlipidemia, familial combined, hyperlipoproteinemia type ii. Across the United States, 136,000 doctors prescribe Ezetimibe to approximately 1.5 million Medicare patients.

## Brand names

Zetia

## Indications

Ezetimibe is prescribed for several conditions including hyperlipidemia, familial combined, hyperlipoproteinemia type ii, among others.

## Conditions treated

- [Hyperlipidemia](https://ourhealthnetwork.com/conditions/hyperlipidemia)
- [Familial Combined](https://ourhealthnetwork.com/conditions/familial-combined)
- [Hyperlipoproteinemia Type II](https://ourhealthnetwork.com/conditions/hyperlipoproteinemia-type-ii)
- [Hypercholesterolemia](https://ourhealthnetwork.com/conditions/hypercholesterolemia)

## Mechanism of action

Ezetimibe and Simvastatin Tablets Plasma cholesterol is derived from intestinal absorption and endogenous synthesis. Ezetimibe and simvastatin tablets contain ezetimibe and simvastatin, two lipid-lowering compounds with complementary mechanisms of action.

## Drug classification

- Established Pharmacologic Class: HMG-CoA Reductase Inhibitor [EPC]
- Mechanism of Action class: Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

and diarrhea, headache, myalgia, upper respiratory tract infection

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)